RNA Sequencing and Bioinformatics Analysis Reveals the Downregulation of DNA Replication Genes by Morindone in

Cheok Wui Chee1, Najihah Mohd Hashim2,3,4, Iskandar Abdullah4,5

  • 1Department of Molecular Medicine, Faculty of Medicine, Universiti Malaya, 50603, Kuala Lumpur, Malaysia.

Insights

Morindone shows potential against colorectal cancer (CRC) by downregulating key DNA replication genes. This study identifies GINS2 as a promising therapeutic target for CRC treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Morindone, a natural anthraquinone, exhibits pharmacological properties in various cancers.
  • Anticancer effects and molecular mechanisms of morindone in colorectal cancer (CRC) are not well understood.

Purpose of the Study:

  • To investigate the anticancer effects of morindone in colorectal cancer (CRC) cell lines.
  • To elucidate the molecular mechanisms underlying morindone's action in CRC using RNA sequencing.

Main Methods:

  • RNA sequencing was employed to identify differentially expressed genes (DEGs) in HCT116 and HT29 CRC cells after morindone treatment.
  • Functional enrichment analysis (Gene Ontology and Kyoto Encyclopaedia of Genes and Genomes) was performed on overlapping DEGs.
  • Seven hub genes were identified and validated using reverse transcription quantitative polymerase chain reaction (rt-qPCR).

Main Results:

  • Morindone treatment led to the downregulation of seven hub genes (MCM5, MCM6, MCM10, GINS2, POLE2, PRIM1, WDHD1) involved in DNA replication.
  • The most significant functional enrichments included negative regulation of cell development and the MAPK signaling pathway.
  • GINS2 was identified as the most cancer-dependent gene, correlating with better survival outcomes in both cell lines.

Conclusions:

  • Morindone demonstrates potential therapeutic benefits for colorectal cancer (CRC).
  • The study identifies key DNA replication genes, particularly GINS2, as potential pharmacological targets for morindone-based CRC therapy.
  • Findings provide a foundation for further investigation into morindone as a CRC treatment.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
S-Cdk Initiates DNA Replication02:38

S-Cdk Initiates DNA Replication

The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
4.7K
The DNA Replication Fork01:02

The DNA Replication Fork

An organism’s genome needs to be duplicated in an efficient and error-free manner for its growth and survival. The replication fork is a Y-shaped active region where two strands of DNA are separated and replicated continuously. The coupling of DNA unzipping and complementary strand synthesis is a characteristic feature of a replication fork.   Organisms with small circular DNA, such as E. coli, often have a single origin of replication; therefore, they have only two replication...
36.1K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K